This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources Aug. 17, 2010
 
ASCLS eNewsBytes
Aug. 17, 2010
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources
 
 

Toward making 'extended blood group typing' more widely available
Science Daily    Share   Share on FacebookTwitterShare on LinkedinE-mail article
Scientists are reporting an advance toward enabling more blood banks to adopt so-called "extended blood group typing," which increases transfusion safety by better matching donors and recipients. Their report on a new, automated genetic method for determining a broader range of blood types appears in ACS' Analytical Chemistry. Christophe Marquette and colleagues explain that most blood banks still use a century-old blood approach to blood typing. It identifies blood group antigens on red blood cells — proteins that must match in donor and recipient to avoid potentially serious transfusion reactions. More



Aggressive glucose control in patients with diabetes and kidney disease not associated with improved survival
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aggressive control of glycosylated hemoglobin (HbA1c) levels in patients with diabetes and end-stage kidney failure is not associated with decreased mortality in this population, suggesting that clinicians should avoid aggressive glucose management and aim for the recommended HbA1c level of less than 7 percent in all patients. Mark E. Williams, MD, from the Renal Unit, Joslin Diabetes Center, in Boston, Massachusetts, and colleagues reported their findings online in the Clinical Journal of the American Society of Nephrology. More

CDC: Fruit pulp linked to rare US typhoid cases
The Associated Press via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A rare U.S. outbreak of typhoid fever has been linked to a frozen tropical fruit product used to make smoothies, health officials reported. Seven cases have been confirmed — three in California and four in Nevada. Two more California cases are being investigated. Five people were hospitalized, according to the Centers for Disease Control and Prevention said. The CDC said five of the victims drank milkshakes or smoothies made with frozen mamey (ma-MAY') fruit pulp. Four of them used pulp sold by Goya Foods Inc. of Secaucus, N.J. More

Clinical pathology labs should plan on greater transparency in test prices and patient outcomes
DARKDaily.com    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
At both the federal and state level, the trend toward greater transparency in health-care pricing continues to spread. This is a trend which is designed to require providers—including clinical laboratories and pathology groups—to make their prices for laboratory testing easily accessible to patients and consumers. Across the nation, federal and state governments are implementing policies aimed at helping consumers make informed health-care decisions. More



Mosquitoes carrying virus found in Boston
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For the first time this summer, mosquitoes carrying West Nile virus have been discovered in Boston, public health authorities reported. The infected insects, which can spread the virus to people through bites, were found in the northern part of Dorchester, Mass. No human cases of West Nile have been reported so far this year in Boston or elsewhere in Massachusetts. The most recent human case of the disease in the state was reported in 2008. More

Rates of invasive healthcare-associated MRSA infections may be declining
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Rates of invasive healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections have decreased during the past four years, according to the results of a study reported in the Journal of the American Medical Association. "[MRSA] is a pathogen of public health importance; MRSA prevention programs that may affect MRSA transmission and infection are increasingly common in health care settings," write Alexander J. Kallen, MD, MPH, from the US Centers for Disease Control in Atlanta and colleagues from the Active Bacterial Core surveillance MRSA Investigators of the Emerging Infections Program. "Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing." More

Bio-Rad's MRSASelect™ - Results on Your Time

Chromogenic Medium for Screening MRSA
With high sensitivity and specificity, this test can identify MRSA carriers in just 18–28 hours. The test procedure is simple, and results are easy to read and interpret. 
MORE


Selected cells from blood or bone marrow may provide a route to healing blood vessels
EurekAlert via Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow. More

Stem cell therapy appears successful in treating rare, deadly skin disease
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Stem cell therapies hold enormous promise. But, so far, there are few confirmed stem cell treatments beyond traditional bone marrow transplantation. Researchers reported, however, that they have been able to use stem cells to treat a rare, often-fatal skin disease in children. The results of the experimental therapy suggest that stem cells from bone marrow can travel to injured skin cells and repair damage to those cells. More
 
 
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Jonathan Berger, Director of Advertising Sales
469.420.2633

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Dedicated - Helmer August 2010
  • Aug. 10, 2010
  • Aug. 3, 2010
  • July 27, 2010
  • July 20, 2010
  •  RSS Feed
    Most popular articles